{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:09:52Z","timestamp":1777532992545,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1067\/mhj.2002.121261","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T21:24:11Z","timestamp":1034198651000},"page":"1068-1075","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?"],"prefix":"10.1067","volume":"143","author":[{"given":"Paul A.","family":"Gurbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Gattis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey F.","family":"Fuzaylov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gaulden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vic","family":"Hasselblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor L.","family":"Serebruany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.121261_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.CIR.60.3.497","article-title":"Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside","volume":"60","author":"Mehta","year":"1979","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.121261_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0038-1646427","article-title":"Platelet survival in patients with dilated cardiomyopathy","volume":"66","author":"Weidinger","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.121261_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/14.2.205","article-title":"Platelet function, thrombin and fibrinolytic activity in patients with heart failure","volume":"14","author":"Jafri","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.121261_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9149(99)00098-3","article-title":"Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure","volume":"83","author":"O'Connor","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.121261_bib5","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.10.6.1032","article-title":"Whole blood impedence aggregometry and ischemic heart disease: the Caerphilly Collaborative Heart Disease Study","volume":"10","author":"Elwood","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1067\/mhj.2002.121261_bib6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0735-1097(98)00172-7","article-title":"Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment","volume":"31","author":"Gurbel","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.121261_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-8703(00)90242-4","article-title":"Role of soluble and platelet-bound p-selectin in discriminating cardiac from non-cardiac chest pain at presentation in the emergency department","volume":"139","author":"Gurbel","year":"2000","journal-title":"Am Heart J"},{"issue":"2 Suppl","key":"10.1067\/mhj.2002.121261_bib8","first-page":"113","article-title":"Preliminary data from a field trial of the PFA-100 system","volume":"21","author":"Mammen","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1067\/mhj.2002.121261_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","article-title":"PFA-100 system: a new method for assessment of platelet dysfunction","volume":"24","author":"Mammen","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1067\/mhj.2002.121261_bib10","first-page":"312","article-title":"Measurement of platelet force: the hemodyne hemostasis analyzer","volume":"9","author":"Carr","year":"1995","journal-title":"Clin Lab Manage Rev"},{"key":"10.1067\/mhj.2002.121261_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1054\/plef.1999.0064","article-title":"Plasma thromboxane and prostacyclin are linearly related and increased in patients presenting with acute myocardial infarction","volume":"61","author":"Gurbel","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"L Suppl","key":"10.1067\/mhj.2002.121261_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/16.suppl_L.11","article-title":"The role of platelets in arterial thrombosis and the rationale for blockade of platelet GP IIb\/IIIa receptors as antithrombotic therapy","volume":"16","author":"Coller","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.121261_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V88.3.907.907","article-title":"Analysis of GP IIb\/IIIa receptor number by quantification of 7E3 binding to human platelets","volume":"88","author":"Wagner","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mhj.2002.121261_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0038-1646488","article-title":"Biochemical characterization of PECAM-1 (CD 31 antigen) on human platelets","volume":"66","author":"Metzelaar","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2002.121261_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.ATV.19.1.153","article-title":"Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction","volume":"19","author":"Serebruany","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2002.121261_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V91.2.500","article-title":"Platelet\/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregration of human platelets","volume":"91","author":"Varon","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mhj.2002.121261_bib17","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1074\/jbc.272.13.8137","article-title":"Agonist-activated alphavBeta3 on platelets and lymphocytes binds to the matrix protein osteopontin","volume":"272","author":"Bennett","year":"1997","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1067\/mhj.2002.121261_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0098-2997(97)00012-5","article-title":"Could coenzyme Q10 affect hemostasis by inhibiting platelet vtironectin (CD51\/CD61) receptor?","volume":"18","author":"Serebruany","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1067\/mhj.2002.121261_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1345\/aph.18129","article-title":"Interaction of ACE inhibitors and aspirin in patients with congestive heart failure","volume":"33","author":"Song","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1067\/mhj.2002.121261_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mcp.2000.106290","article-title":"Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure","volume":"67","author":"Davie","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1067\/mhj.2002.121261_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-8703(99)70109-2","article-title":"Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors","volume":"138","author":"Guazzi","year":"1999","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.121261_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9149(96)00696-0","article-title":"Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II","volume":"79","author":"Nguyen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.121261_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-8703(99)70099-2","article-title":"The interaction between ACE-inhibitors and aspirin in heart failure: torn between two lovers","volume":"138","author":"Teerlink","year":"1999","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.121261_bib24","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0272-6386(96)90565-X","article-title":"Does aspirin cause acute or chronic renal failure in experimental animals and in humans?","volume":"28","author":"D'Agati","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mhj.2002.121261_bib25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a asystematic overview of data from individual patients. Ace Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.121261_bib26","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0735-1097(99)00129-1","article-title":"Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease","volume":"33","author":"Leor","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.121261_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.160.10.1409","article-title":"Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?","volume":"160","author":"Stys","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1067\/mhj.2002.121261_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1388-9842(99)00059-8","article-title":"Meeting report: the LIDO, HOPE, MOXCON and WASH studies. Heart Outcomes Prevention Evaluation. The warfarin\/aspirin study of heart failure","volume":"1","author":"Jones","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"10.1067\/mhj.2002.121261_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-8703(98)70212-1","article-title":"Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction","volume":"136","author":"Serebruany","year":"1998","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.121261_bib30","first-page":"127","article-title":"Myocardial cell injury during ischemia and reflow","author":"Gurbel","year":"1998"},{"key":"10.1067\/mhj.2002.121261_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.121261_bib32","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.121261_bib33","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"issue":"6 Suppl","key":"10.1067\/mhj.2002.121261_bib34","first-page":"40","article-title":"Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II","volume":"87","author":"Francis","year":"1993","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.121261_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-8703(94)90670-X","article-title":"Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure","volume":"127","author":"Sbarouni","year":"1994","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.121261_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0002-9149(97)00013-1","article-title":"Effect of antithrombotic therapy or risk of sudden coronary death in patients with congestive heart failure","volume":"79","author":"Dries","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.121261_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0735-1097(97)00502-0","article-title":"Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial","volume":"31","author":"Al Khadra","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"6 Suppl","key":"10.1067\/mhj.2002.121261_bib38","first-page":"94","article-title":"The V-HeFT VA cooperative Studies Group","volume":"87","author":"Dunkman","year":"1993","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:03:33Z","timestamp":1583413413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0002870302000248"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.121261","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}